FDA Grants Approval for Propranolol Hydrochloride ANDA219165
The FDA has granted approval for the ANDA219165 application for Propranolol Hydrochloride submitted by PAI Holdings.
Therapeutic Area
Therapeutic area intelligence for Beta-blocker with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.